Skip to main content
Premium Trial:

Request an Annual Quote

Biodesix Using VeriStrat to Evaluate Kadmon's Tyrosine Kinase Inhibitor

NEW YORK (GenomeWeb News) – Biodesix today announced it is collaborating with biopharma Kadmon to evaluate the use of Biodesix's test for a non-small cell lung cancer study for Kadmon's reversible tyrosine kinase inhibitor.

The Phase 3 study is designed to compare Kadmon's TKI called KD019 with erlotinib in patients with stage IIIB/IV NSCLC who have progressed after first- or second-line chemotherapy. KD019 targets EGFR, HER2, VEGFR2 and 3, and SRC, and Biodesix's VeriStrat test will be used on serum samples from the study. The test will be evaluated for its effectiveness in identifying patients with better or worse outcomes following treatment with KD019, Biodesix said.

Terms of the deal were not disclosed.

Partnering with biopharmas has been a strategy of Biodesix to increase adoption of its VeriStrat, a laboratory developed test launched in 2009, and a company official said in January that it was progressing on those efforts.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.